← back to search

Jin‐Hu Fan

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Surgery · Oncology
Research interest
Research interests include Esophageal Cancer Research and Treatment, Breast Cancer Treatment Studies, Helicobacter pylori-related gastroenterology studies, and Global Cancer Incidence and Screening.
h-index
38
citations
6,765
works
193
NIH funding
primary concept
email

Recent publications

1470O Perioperative camrelizumab plus rivoceranib in resectable hepatocellular carcinoma (CARES-009): A randomized, multicenter, phase III trial
Annals of Oncology 2025cited by 0position: middledoi
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
Frontiers in Oncology 2023cited by 29position: firstdoi
Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
2022cited by 11position: contributordoi
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China
Annals of Translational Medicine 2022cited by 7position: middledoi
The Association Between Family History of Upper Gastrointestinal Cancer and the Risk of Death from Upper Gastrointestinal Cancer-based on Linxian Dysplasia Nutrition Intervention Trial (NIT) Cohort.
2022cited by 6position: contributordoi
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.
2022cited by 5position: contributordoi
Combined Lifestyle Factors and Risk of All-Cause and Cause-Specific Mortality Among Participants in the Linxian Nutrition Intervention Trial: A Cohort, Observational Study.
2022cited by 3position: contributordoi
Mortality after multivitamin supplementation: Nearly 35-year follow-up of the randomized Linxian Dysplasia Nutrition Intervention Trial.
2022cited by 1position: contributordoi
Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey
Cancer 2021cited by 106position: middledoi
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
2021cited by 15position: contributordoi
ABO genotypes and the risk of esophageal and gastric cancers.
2021cited by 11position: contributordoi
Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population.
2021cited by 10position: contributordoi
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
Cancer Medicine 2021cited by 9position: middledoi
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China
Journal of Oncology 2021cited by 7position: middledoi
Colorectal cancer in the Linxian China Nutrition Intervention Trial: Risk factors and intervention results.
2021cited by 7position: contributordoi
Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective study.
2021cited by 7position: contributordoi
A long-term follow-up analysis of associations between tooth loss and multiple cancers in the Linxian General Population Cohort.
2021cited by 7position: contributordoi
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
Cancer Medicine 2021cited by 7position: contributordoi
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
Frontiers in Oncology 2021cited by 6position: middledoi
Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case-Control Study.
2021cited by 6position: contributordoi
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China.
2021cited by 5position: contributordoi
Association between serum ferritin, incident primary liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: A nested case-control study.
2021cited by 4position: contributordoi
Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.
2020cited by 27position: contributordoi
Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
2020cited by 20position: contributordoi
Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study
International Journal of Cancer 2020cited by 17position: middledoi
Fresh fruit consumption may decrease the long‐term risk of esophageal cancer mortality: A 30‐year follow‐up study in the Linxian Dysplasia Nutrition Intervention trial (NIT)
Thoracic Cancer 2020cited by 11position: contributordoi
Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort.
2020cited by 8position: contributordoi
Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population
Thoracic Cancer 2020cited by 5position: contributordoi
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China.
2020cited by 4position: contributordoi
Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case-Control Study.
2020cited by 4position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

You-Lin Qiao · Renmin Hospital of Wuhan University21 papers (2019–2022)Christian C. Abnet · Indiana University – Purdue University Indianapolis5 papers (2019–2021)Neal D. Freedman · University of Minho5 papers (2020–2021)You‐Lin Qiao · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2012–2022)Su Zhang · Fujian Medical University4 papers (2019–2021)Shusen Wang · Nanjing Medical University3 papers (2021–2022)Binghe Xu · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2021–2021)Huan Yang · Yunnan University3 papers (2020–2022)Sanford M. Dawsey · National Institutes of Health3 papers (2019–2021)Li Cai · Zhengzhou University2 papers (2021–2022)Yiqun Han · Mayo Clinic2 papers (2021–2021)Zhikai Zhu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2021) · 2 papers (2020–2021)Gwen Murphy · Department of Health and Human Services2 papers (2019–2020) · 2 papers (2021–2021) · 2 papers (2019–2020)Wen Chen · National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital2 papers (2020–2021)Tao Peng · Beijing Institute of Technology1 papers (2025–2025)Liyuan Peng · Ministry of Education1 papers (2025–2025)Xiaojia Wang · Beijing University of Chinese Medicine1 papers (2022–2022)